In a recent study published in the journal Current Medical Research and Opinion, researchers report that high lipoprotein(a) levels were linked to repeated coronary heart disease events in older ...

Routine blood tests in the not-too-distant future may feature a new line item: lipoprotein(a). High levels of this fat- and cholesterol-carrying protein increase the risk of cardiovascular disease, ...

High blood levels of the lipid lipoprotein(a) in people with type 1 diabetes add to the already elevated risk of developing cardiovascular disease, researchers from Karolinska Institutet in Sweden ...

Previous studies have indicated an association between circulating lipoprotein(a) levels and coronary heart disease (CHD). Now, Bennet et al. have conducted a large-scale study to assess the nature of ...

Lipoprotein(a) has been linked to aortic stenosis and atherosclerosis. Lipoprotein(a) is formed by the interaction of apolipoprotein(a) with apolipoprotein B100. Muvalaplin, a small molecule drug, ...

Barriers to the routine measurement of lipoprotein(a) (Lp(a)) levels in clinical practice have now been addressed by a large, global case-control study of myocardial infarction (MI). Despite strong ...

"Medical Journeys" is a set of clinical resources reviewed by doctors, meant for physicians and other healthcare professionals as well as the patients they serve. Each episode of this journey through ...

Deleterious effect of lipoprotein(a) ≥180 nmol/L possibly mitigated by high-impact LDL-cholesterol-lowering therapy. (HealthDay News) — Higher lipoprotein(a) levels are associated with continuously ...

Reduction in levels seen using an intact lipoprotein(a) assay and apolipoprotein(a)-based assay. (HealthDay News) — Muvalaplin reduces lipoprotein(a) levels, according to a study published online in ...

A panel discussion titled “Elevated Lipoprotein(a): Raise Your Game and Lower Your (Risk) Score?” presented at the American Heart Association (AHA) Scientific Sessions 2023, which convened in ...

Authors say findings call for primary prevention strategies to extend beyond traditional 10-year estimates. HealthDay News — A single combined measure of high-sensitivity C-reactive protein (CRP), low ...

A new analysis has uncovered a potential link between higher prostate cancer risk and genetic variants associated with higher bloodstream levels of the cholesterol-transporting molecule lipoprotein A.